ARTICLE | Company News
Medivir UK Ltd., University of London School of Medicine and Dentistry deal
September 4, 2001 7:00 AM UTC
Medivir UK, part of Medivir AB (SSE:MVIR, Huddinge, Sweden) will develop protease inhibitors as specific antimicrobials against Mycobacterium tuberculosis, Helicobacter pylori, Pseudomonas aeruginosa...